Skip to content
healthcare.dev

Survanta

NDC 0074-1040, Beractant, suspension, from AbbVie Inc..

Product NDC
0074-1040
Status
Listed
Labeler
AbbVie Inc.
Dosage form
SUSPENSION
Route
ENDOTRACHEAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA020032
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0074-1040 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • BERACTANT25 mg/mL
Package NDCNDC-11Package
0074-1040-04000741040041 VIAL, SINGLE-USE in 1 CARTON (0074-1040-04) / 4 mL in 1 VIAL, SINGLE-USE
0074-1040-08000741040081 VIAL, SINGLE-USE in 1 CARTON (0074-1040-08) / 8 mL in 1 VIAL, SINGLE-USE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/7ef9e3a5-fc39-4ae1-0dad-6b47a1684635

Use it

Look up 0074-1040 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0074-1040 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0074-1040. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.